Annual maintenance agreement for combiflash RF/RF+ chromatography systems (POP: 06/28/21 to 06/27/22)

Ended Purchase Order Awarded Last action

Contract number
75N95021P00279
Awardee
Awarding agency
Obligated
$135,752

Award facts

Opportunity
Contract value 75% obligated
  • $135,752.00 Current, with exercised options
  • $180,446.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lincoln, NE 68501, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 $44,694
Exercise an Option P00001 $44,694
Original award $46,364

About this award

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Teledyne Instruments, Inc. (Teledyne Isco division) for an annual maintenance agreement for CombiFlash RF/RF+ chromatography systems. The contract has a potential value of $180,446.00 and a period of performance from June 28, 2021 to June 27, 2025. This award was made on a sole-source basis to the original equipment manufacturer, as Teledyne Isco claims to be the sole provider for maintenance and repair of the systems. The systems are critical to the NCATS Chemistry group's mission of synthesizing small molecule biological probes, and routine maintenance is required to ensure the instruments operate properly and maximize productivity.

Quick answers

Who was awarded contract 75N95021P00279?

75N95021P00279 was awarded to Teledyne Instruments, Inc. by National Institute on Drug Abuse (National Institutes of Health) on June 28, 2021.

How much is contract 75N95021P00279 worth?

The government has obligated $135,752 on 75N95021P00279. Its potential value, with all options, is $180,446.

Which agency awarded contract 75N95021P00279?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00279, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95021P00279 competed?

The extent of competition for 75N95021P00279 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award